We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1601
Byline Bancorp
BY
$1.68B
| $1.6M | ﹤0.01% |
+50,614
| New | +$1.59M |
2026 Q1
0 quarters
|
|
1602
KKR & Co
KKR
$77.4B
| $1.59M | ﹤0.01% |
17,239
-30,685
| -64% | -$3.23M |
2024 Q1
8 quarters
|
|
1603
Vir Biotechnology
VIR
$1.69B
| $1.59M | ﹤0.01% |
+177,924
| New | +$1.42M |
2026 Q1
0 quarters
|
|
1604
Diebold Nixdorf
DBD
$2.27B
| $1.59M | ﹤0.01% |
+21,130
| New | +$1.55M |
2026 Q1
0 quarters
|
|
1605
Rocket Lab Corp
RKLB
$32.5B
| $1.59M | ﹤0.01% |
24,782
-108,737
| -81% | -$8.2M |
2024 Q4
5 quarters
|
|
1606
Petrobras
PBR
$168B
| $1.59M | ﹤0.01% |
76,657
-522,111
| -87% | -$8.35M |
2025 Q3
2 quarters
|
|
1607
Ovintiv
OVV
$19.2B
| $1.58M | ﹤0.01% |
+26,670
| New | +$1.29M |
2026 Q1
0 quarters
|
|
1608
Regenxbio
RGNX
$457M
| $1.57M | ﹤0.01% |
187,625
+124,054
| +195% | +$1.3M |
2025 Q1
4 quarters
|
|
1609
Asbury Automotive
ABG
$3.05B
| $1.57M | ﹤0.01% |
+8,013
| New | +$1.78M |
2026 Q1
0 quarters
|
|
1610
Aflac
AFL
$60.1B
| $1.55M | ﹤0.01% |
14,105
-147,132
| -91% | -$16.3M |
2023 Q4
9 quarters
|
|
1611
BOK Financial
BOKF
$7.59B
| $1.53M | ﹤0.01% |
11,959
+1,661
| +16% | +$213K |
2025 Q4
1 quarter
|
|
1612
Kforce
KFRC
$914M
| $1.52M | ﹤0.01% |
51,950
+26,773
| +106% | +$813K |
2025 Q2
3 quarters
|
|
1613
Arcutis Biotherapeutics
ARQT
$3.62B
| $1.51M | ﹤0.01% |
64,219
+55,260
| +617% | +$1.41M |
2025 Q4
1 quarter
|
|
1614
UFP Technologies
UFPT
$2.26B
| $1.51M | ﹤0.01% |
7,787
+4,795
| +160% | +$1.11M |
2025 Q4
1 quarter
|
|
1615
Amcor
AMCR
$20.3B
| $1.5M | ﹤0.01% |
37,838
-118,866
| -76% | -$5.26M |
2025 Q2
3 quarters
|
|
1616
Ocular Therapeutix
OCUL
$1.51B
| $1.5M | ﹤0.01% |
177,468
+131,379
| +285% | +$1.25M |
2025 Q4
1 quarter
|
|
1617
Conagra Brands
CAG
$6.91B
| $1.5M | ﹤0.01% |
95,502
-101,467
| -52% | -$1.79M |
2025 Q4
1 quarter
|
|
1618
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.05B
| $1.49M | ﹤0.01% |
+29,900
| New | +$1.5M |
2026 Q1
0 quarters
|
|
|
1619
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.05B
| $1.49M | ﹤0.01% |
+29,900
| New | +$1.5M |
2026 Q1
0 quarters
|
|
1620
Avnet
AVT
$7.4B
| $1.49M | ﹤0.01% |
24,217
-78,996
| -77% | -$4.7M |
2025 Q4
1 quarter
|
|
1621
Ambarella
AMBA
$2.72B
| $1.49M | ﹤0.01% |
28,984
+4,139
| +17% | +$258K |
2023 Q4
9 quarters
|
|
1622
Klaviyo
KVYO
$4.86B
| $1.49M | ﹤0.01% |
+76,651
| New | +$1.64M |
2026 Q1
0 quarters
|
|
1623
Kinsale Capital Group
KNSL
$8.32B
| $1.48M | ﹤0.01% |
4,346
-10,012
| -70% | -$3.79M |
2023 Q4
9 quarters
|
|
1624
PTC
PTC
$21B
| $1.48M | ﹤0.01% |
10,405
-59,845
| -85% | -$9.46M |
2023 Q4
9 quarters
|
|
1625
Evolv Technologies
EVLV
$753M
| $1.48M | ﹤0.01% |
+244,935
| New | +$1.43M |
2026 Q1
0 quarters
|
|
Similar funds
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.